Repligen Corporation (NASDAQ:RGEN) is a life sciences company and bioprocessing tools provider focused on the development, production and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Our products are developed under an ISO9001 quality management system and sold to major life sciences and biopharmaceutical companies worldwide. Our products enable customers to efficiently manufacture a broad range of biological drugs, including monoclonal antibodies, recombinant proteins, vaccines, and gene therapies. Focused on cost and process efficiencies, we deliver innovative technologies and solutions that help set new standards in bioprocessing. Our mission is to inspire advances in bioprocessing as a trusted partner in the production of biologic drugs that improve global human health. Repligen is headquartered in Waltham, MA (USA), near the heart of Boston, with major manufacturing sites in Massachusetts, New York, California, Ireland, Sweden, and Germany.
Our mission is to inspire advances in bioprocessing as a trusted partner in the production of biologic drugs that improve human health worldwide. Focused on cost and process efficiencies, we deliver innovative technologies and solutions that help set new standards in bioprocessing. The estimated base salary range for this role, based in the United States of America is $90,000-125,000. Compensation decisions are dependent on several factors including, but not limited to an individual's qualifications, location, internal equity, and alignment with market data. Additionally, employees are eligible to participate in one of our variable cash programs (bonus or commission) and eligible roles may receive equity as part of the compensation package. We offer a wide range of benefits such as paid time off, health/dental/vision, retirement benefits and flexible spending accounts. All compensation and benefits information will be confirmed in writing at the time of offer.
Software Powered by iCIMS
www.icims.com